Table 3.
Average | Nevus classification | ||||||||
---|---|---|---|---|---|---|---|---|---|
Method | AC | AC | F1-score | Pre | SP | ||||
Swin Transformer Liu et al. (2021) | 80.22 | 89.50 | 81.18 | 62.16 | 91.76 | ||||
AION Gehlot and Gupta (2021) | 81.55 | 85.33 | 76.01 | 50.74 | 86.86 | ||||
TransMed Dai et al. (2021) | 84.11 | 89.19 | 80.10 | 61.90 | 92.16 | ||||
MobileNetV3 Howard et al. (2019) | 84.89 | 89.33 | 81.53 | 60.83 | 90.78 | ||||
EfficientNet-B3 Tan and Le (2019) | 85.22 | 90.67 | 82.64 | 66.67 | 93.33 | ||||
Inception v4 Szegedy et al. (2016) | 85.33 | 89.16 | 81.45 | 60.16 | 90.39 | ||||
ResNet50 He et al. (2016) | 85.44 | 91.00 | 82.97 | 68.37 | 93.92 | ||||
DenseNet201 Huang et al. (2017) | 86.56 | 92.00 | 85.36 | 69.81 | 93.73 | ||||
O-Net | 87.22 | 91.67 | 83.51 | 72.73 | 95.29 | ||||
Average | Melanoma classification | Keratosis classification | |||||||
Method | AC | AC | F1-score | Pre | SP | AC | F1-score | Pre | SP |
Swin Transformer Liu et al. (2021) | 80.22 | 73.00 | 71.63 | 84.07 | 73.91 | 78.17 | 68.45 | 45.33 | 83.02 |
AION Gehlot and Gupta (2021) | 81.55 | 77.33 | 75.69 | 85.40 | 74.40 | 82.00 | 69.73 | 54.46 | 90.48 |
TransMed Dai et al. (2021) | 84.11 | 79.17 | 77.13 | 84.72 | 71.50 | 84.00 | 79.83 | 59.63 | 55.56 |
MobileNetV3 Howard et al. (2019) | 84.89 | 80.50 | 78.78 | 86.51 | 75.36 | 84.83 | 74.59 | 62.75 | 92.13 |
EfficientNet-B3 Tan and Le (2019) | 85.22 | 80.50 | 78.82 | 86.70 | 75.85 | 84.50 | 75.71 | 59.84 | 89.86 |
Inception v4 Szegedy et al. (2016) | 85.33 | 80.83 | 79.05 | 86.39 | 74.88 | 86.00 | 75.94 | 67.37 | 93.58 |
ResNet50 He et al. (2016) | 85.44 | 81.50 | 79.99 | 87.90 | 78.26 | 83.83 | 75.28 | 57.69 | 88.61 |
DenseNet201 Huang et al. (2017) | 86.56 | 83.50 | 81.55 | 86.57 | 73.91 | 84.17 | 72.48 | 61.96 | 92.75 |
O-Net | 87.22 | 84.17 | 81.58 | 84.49 | 67.63 | 85.83 | 74.19 | 70.00 | 95.03 |
Bold font to highlight the optimal values.